Synapse - Works

Results (4073)

The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer: Implications for immunotherapy

Meeting Abstract

Lee, M. C.; Kadota, K.; Ujiie, H.; Rizk, N. P.; Travis, W. D.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Pilot trial of an adjuvant pentavalent vaccine for patients with small cell lung cancer (SCLC)

Meeting Abstract

Krug, L. M.; Varghese, A.; Ragupathi, G.; George, C.; Sawada, R.; Scholz, W. W.; Hansen, D.; Livingston, P. O.; Delasos, L.; Pietanza, M. C.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Treatment with therapies matched to oncogenic drivers improves survival in patients with lung cancers: Results from the Lung Cancer Mutation Consortium (LCMC)

Meeting Abstract

Kris, M. G.; Johnson, B.; Berry, L.; Kwiatkowski, D.; Iafrate, A. J.; Wistuba, I.; Varella-Garcia, M.; Franklin, W.; Aronson, S.; Su, P. F.; more...
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Results with dacomitinib (PF-00299804), an irreversible PAN-HER tyrosine kinase inhibitor, in a phase II cohort of patients with HER2-mutant or amplified lung cancers

Meeting Abstract

Kris, M. G.; Camidge, D. R.; Giaccone, G.; Hida, T.; O'Connell, J.; Taylor, I.; Zhang, H.; Gold-Berg, Z.; Jänne, P. A.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

A phase 2 randomized, double-blind, placebo-controlled, multicenter study of VS-6063 as maintenance therapy in subjects with malignant pleural mesothelioma which has not progressed on at least 4 cycles of pemetrexed/platinum therapy

Meeting Abstract

Keegan, M.; Baas, P.; Fennell, D.; Gralla, R. J.; Kindler, H.; Krug, L. M.; Nowak, A. K.; Schwartz, L. H.; Horobin, J. C.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

In patients with stage I lung adenocarcinoma, tumor budding is a significant prognostic factor for recurrence, independent of the IASLC/ATS/ERS classification, and correlates with a protumor immune microenvironment

Meeting Abstract

Kadota, K.; Yeh, Y. C.; Rizk, N. P.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Reclassification of resected non-small cell lung carcinomas originally diagnosed as squamous cell carcinoma, after reevaluation using immunohistochemical analysis (P40, P63, TTF-1, and napsin A): Memorial Sloan-Kettering Cancer Center experience

Meeting Abstract

Kadota, K.; Nitadori, J.; Rusch, V. W.; Rekhtman, N.; Sarkaria, I. S.; Adusumilli, P. S.; Travis, W. D.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Tumor budding and nuclear grade, but not histologic subtype, are significant prognostic factors, independent of TNM stage, in patients with lung squamous cell carcinoma

Meeting Abstract

Kadota, K.; Nitadori, J.; Finley, D. J.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

FGFR1 amplification is associated with improved survival in patients with early-stage squamous cell carcinomas of the lung (SQCLC)

Meeting Abstract

Hellmann, M. D.; Wynne, M.; Wang, L.; Kris, M. G.; Sima, C. S.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Tumor expression of TTF1 is associated with a doubling of overall survival in patients with advanced lung adenocarcinomas

Meeting Abstract

Hellmann, M. D.; Hilden, P. D.; Sima, C. S.; Kris, M. G.; Rekhtman, N.; Chaft, J. E.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save